Literature DB >> 14636947

Akt/PKB kinase phosphorylates separately Thr212 and Ser214 of tau protein in vitro.

Hanna Ksiezak-Reding1, Han Kyoung Pyo, Boris Feinstein, Giulio M Pasinetti.   

Abstract

Microtubule-associated protein tau contains a consensus motif for protein kinase B/Akt (Akt), which plays an essential role in anti-apoptotic signaling. The motif encompasses the AT100 double phospho-epitope (Thr212/Ser214), a specific marker for Alzheimer's disease (AD) and other neurodegenerations, raising the possibility that it could be generated by Akt. We studied Akt-dependent phosphorylation of tau protein in vitro. We found that Akt phosphorylated both Thr212 and Ser214 in the longest and shortest tau isoforms as determined using phospho site-specific antibodies against tau. Akt did not phosphorylate other tau epitopes, including Tau-1, AT8, AT180, 12E8 and PHF-1. The Akt-phosphorylated tau retained its initial electrophoretic mobility. Immunoprecipitation studies with phospho-specific Thr212 and Ser214 antibodies revealed that only one of the two sites is phosphorylated per single tau molecule, resulting in tau immunonegative for AT100. Mixed kinase studies showed that prior Ser214 phosphorylation by Akt blocked protein kinase A but not GSK3beta activity. On the other hand, GSK3beta selectively blocked Ser214 phosphorylation, which was prevented by lithium. The results suggest that Akt may be involved in AD-specific phosphorylation of tau at the AT100 epitope in conjunction with other kinases. Our data suggest that phosphorylation of tau by Akt may play specific role(s) in Akt-mediated anti-apoptotic signaling, particularly relevant to AD and other neurodegenerations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14636947     DOI: 10.1016/j.bbadis.2003.09.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  42 in total

1.  Presenilins regulate the cellular level of the tumor suppressor PTEN.

Authors:  Han Zhang; Runzhong Liu; Ruishan Wang; Shuigen Hong; Huaxi Xu; Yun-wu Zhang
Journal:  Neurobiol Aging       Date:  2007-01-12       Impact factor: 4.673

2.  Rho-kinase ROCK inhibitors reduce oligomeric tau protein.

Authors:  Tadanori Hamano; Norimichi Shirafuji; Shu-Hui Yen; Hirotaka Yoshida; Nicholas M Kanaan; Kouji Hayashi; Masamichi Ikawa; Osamu Yamamura; Youshi Fujita; Masaru Kuriyama; Yasunari Nakamoto
Journal:  Neurobiol Aging       Date:  2019-12-16       Impact factor: 4.673

3.  Proteasome inhibition-induced downregulation of Akt/GSK-3β pathway contributes to abnormality of tau in hippocampal slice.

Authors:  Min Xie; Ruihong Shi; Ying Pan; Tao Zeng; Qicai Chen; Shaohui Wang; Xiaomei Liao
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

4.  Association between Polymorphisms of the AKT1 Gene Promoter and Risk of the Alzheimer's Disease in a Chinese Han Population with Type 2 Diabetes.

Authors:  Sheng-Yuan Liu; He-Dan Zhao; Jin-Long Wang; Tong Huang; Hua-Wei Tian; Li-Fen Yao; Hua Tao; Zhong-Wei Chen; Chang-Yi Wang; Si-Tong Sheng; Hua Li; Bin Zhao; Ke-Shen Li
Journal:  CNS Neurosci Ther       Date:  2015-07-14       Impact factor: 5.243

5.  Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-D-aspartate receptor-dependent tau phosphorylation.

Authors:  Siddhartha Mondragón-Rodríguez; Emilie Trillaud-Doppia; Anthony Dudilot; Catherine Bourgeois; Michel Lauzon; Nicole Leclerc; Jannic Boehm
Journal:  J Biol Chem       Date:  2012-07-25       Impact factor: 5.157

6.  Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy.

Authors:  Monica Javidnia; Michaeline L Hebron; Yue Xin; Nikolas G Kinney; Charbel E-H Moussa
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

7.  Mammalian target of rapamycin (mTor) mediates tau protein dyshomeostasis: implication for Alzheimer disease.

Authors:  Zhi Tang; Erika Bereczki; Haiyan Zhang; Shan Wang; Chunxia Li; Xinying Ji; Rui M Branca; Janne Lehtiö; Zhizhong Guan; Peter Filipcik; Shaohua Xu; Bengt Winblad; Jin-Jing Pei
Journal:  J Biol Chem       Date:  2013-04-12       Impact factor: 5.157

Review 8.  Transgenic models of Alzheimer's disease: better utilization of existing models through viral transgenesis.

Authors:  Thomas L Platt; Valerie L Reeves; M Paul Murphy
Journal:  Biochim Biophys Acta       Date:  2013-04-22

9.  Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia.

Authors:  Emmanuel Planel; Alexis Bretteville; Li Liu; Laszlo Virag; Angela L Du; Wai Haung Yu; Dennis W Dickson; Robert A Whittington; Karen E Duff
Journal:  FASEB J       Date:  2009-03-11       Impact factor: 5.191

10.  Phosphorylation of the mutant K303R estrogen receptor alpha at serine 305 affects aromatase inhibitor sensitivity.

Authors:  I Barone; D Iacopetta; K R Covington; Y Cui; A Tsimelzon; A Beyer; S Andò; S A W Fuqua
Journal:  Oncogene       Date:  2010-01-25       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.